Where the Street stands
These are third-party analyst opinions from named firms, not advice, and not a prediction. Earnings land in 11 days, which usually moves targets. How we score this
1 firm currently rating it, weighted by track record.
The 1 firm with a track record here beat the S&P 42% of the time over 12 months.
Pro: see the crowd-vs-sharp split for BRK-BAnalysts rate Berkshire Hathaway a consensus Buy, with an average price target of $520.33 implying 4.7% upside from current levels. UBS has maintained a Buy rating since at least early 2023, most recently on May 4, while TD Cowen initiated a Hold in July 2024. The diversified insurer and investment conglomerate trades at a trailing P/E of 14.79 with EPS growth of 119.60% year-over-year, though forward P/E stands at 23.11 and the company carries minimal debt at a 0.18 debt-to-equity ratio.
Generated from the data on this page; may contain errors. Analyst opinions belong to the named firms. Informational only, not investment advice.
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 4, 2026 | UBS | ○ Maintained | |
| Nov 3, 2025 | UBS | ○ Maintained |
Create a free account to unlock all analyst ratings, key stats, and news. No credit card, takes 30 seconds.
Sign up free